🌱 KidneyEnergy.com

← brief for 2026-10-25 · Slowing decline

Evaluation of the preventive effect of intravenous trans-sodium crocetinate followed by oral crocetin on contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angioplasty: A randomized placebo-controlled triple-blind clinical trial.

Article B Peer reviewed Small trial

Key takeaways

A trial of 130 people found a plant-based antioxidant helped protect kidneys. The medicine was given before a heart scan. It may lower the risk of kidney damage from the dye.

Who did this work

Salari S · Mohammadpour A · Gholoobi A · Ghavami V · Ramezani J · Eshraghi A · Hosseinzadeh H

Source

Article · PubMed, CKD progression and prevention · 2026
https://pubmed.ncbi.nlm.nih.gov/42920967/